Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 WTAP is a novel oncogenic protein in acute myeloid leukemia.

Literature DB >> 24413322

WTAP is a novel oncogenic protein in acute myeloid leukemia.

H Bansal¹, Q Yihua², S P Iyer³, S Ganapathy¹, D A Proia, D Proia⁴, L O Penalva⁵, P J Uren⁶, U Suresh¹, J S Carew⁷, A B Karnad⁸, S Weitman⁷, G E Tomlinson¹, M K Rao⁵, S M Kornblau², S Bansal¹.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2014 PMID： 24413322 PMCID： PMC4369791 DOI： 10.1038/leu.2014.16

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

17 in total

1. Identification of WTAP, a novel Wilms' tumour 1-associating protein.

Authors: N A Little; N D Hastie; R C Davies
Journal: Hum Mol Genet Date: 2000-09-22 Impact factor: 6.150

Review 2. Transcription factors in myeloid development: balancing differentiation with transformation.

Authors: Frank Rosenbauer; Daniel G Tenen
Journal: Nat Rev Immunol Date: 2007-02 Impact factor: 53.106

3. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Authors: G Q Daley; D Baltimore
Journal: Proc Natl Acad Sci U S A Date: 1988-12 Impact factor: 11.205

Review 4. HSP90 and the chaperoning of cancer.

Authors: Luke Whitesell; Susan L Lindquist
Journal: Nat Rev Cancer Date: 2005-10 Impact factor: 60.716

5. The Drosophila fl(2)d gene, required for female-specific splicing of Sxl and tra pre-mRNAs, encodes a novel nuclear protein with a HQ-rich domain.

Authors: L O Penalva; M F Ruiz; A Ortega; B Granadino; L Vicente; C Segarra; J Valcárcel; L Sánchez
Journal: Genetics Date: 2000-05 Impact factor: 4.562

6. Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA.

Authors: Keiko Horiuchi; Michihisa Umetani; Takashi Minami; Hiroto Okayama; Shinji Takada; Masayuki Yamamoto; Hiroyuki Aburatani; Patrick C Reid; David E Housman; Takao Hamakubo; Tatsuhiko Kodama
Journal: Proc Natl Acad Sci U S A Date: 2006-11-06 Impact factor: 11.205

Review 7. Drug therapy for acute myeloid leukemia.

Authors: Martin S Tallman; D Gary Gilliland; Jacob M Rowe
Journal: Blood Date: 2005-05-03 Impact factor: 22.113

Review 8. Acute myeloid leukaemia.

Authors: Elihu Estey; Hartmut Döhner
Journal: Lancet Date: 2006-11-25 Impact factor: 79.321

9. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin.

Authors: E G Mimnaugh; C Chavany; L Neckers
Journal: J Biol Chem Date: 1996-09-13 Impact factor: 5.157

10. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors: Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal: N Engl J Med Date: 2013-05-01 Impact factor: 91.245

105 in total

Review 1. RNA contributions to the form and function of biomolecular condensates.

Authors: Christine Roden; Amy S Gladfelter
Journal: Nat Rev Mol Cell Biol Date: 2020-07-06 Impact factor: 94.444

Review 2. Viral Epitranscriptomics.

Authors: Edward M Kennedy; David G Courtney; Kevin Tsai; Bryan R Cullen
Journal: J Virol Date: 2017-04-13 Impact factor: 5.103

3. Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.

Authors: Jill S Butler; Yi Hua Qiu; Nianxiang Zhang; Suk-Young Yoo; Kevin R Coombes; Sharon Y R Dent; Steven M Kornblau
Journal: Leuk Lymphoma Date: 2016-10-13

Review 4. Regulation of Gene Expression by N⁶-methyladenosine in Cancer.

Authors: Jun Liu; Bryan T Harada; Chuan He
Journal: Trends Cell Biol Date: 2019-03-30 Impact factor: 20.808

Review 5. N6-methyladenine RNA modification and cancers.

Authors: Xia Wu; Lina Sang; Yuping Gong
Journal: Am J Cancer Res Date: 2018-10-01 Impact factor: 6.166

6. Development and validation of a m⁶A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.

Authors: Xinyuan Zhao; Li Cui
Journal: Am J Cancer Res Date: 2019-10-01 Impact factor: 6.166

WTAP is a novel oncogenic protein in acute myeloid leukemia.

1. Identification of WTAP, a novel Wilms' tumour 1-associating protein.

Review 2. Transcription factors in myeloid development: balancing differentiation with transformation.

3. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Review 4. HSP90 and the chaperoning of cancer.

5. The Drosophila fl(2)d gene, required for female-specific splicing of Sxl and tra pre-mRNAs, encodes a novel nuclear protein with a HQ-rich domain.

6. Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA.

Review 7. Drug therapy for acute myeloid leukemia.

Review 8. Acute myeloid leukaemia.

9. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin.

10. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Review 1. RNA contributions to the form and function of biomolecular condensates.

Review 2. Viral Epitranscriptomics.

3. Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.

Review 4. Regulation of Gene Expression by N⁶-methyladenosine in Cancer.

Review 5. N6-methyladenine RNA modification and cancers.

6. Development and validation of a m⁶A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.

Review 7. Role of N⁶-methyladenosine modification in cancer.

Review 8. Cross Talk between Radiation and Immunotherapy: The Twain Shall Meet.

Review 9. m⁶A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

10. Essential role of METTL3-mediated m⁶A modification in glioma stem-like cells maintenance and radioresistance.

Review 2. Transcription factors in myeloid development: balancing differentiation with transformation.

Review 4. HSP90 and the chaperoning of cancer.

Review 7. Drug therapy for acute myeloid leukemia.

Review 8. Acute myeloid leukaemia.

Review 1. RNA contributions to the form and function of biomolecular condensates.

Review 2. Viral Epitranscriptomics.

Review 4. Regulation of Gene Expression by N6-methyladenosine in Cancer.

Review 5. N6-methyladenine RNA modification and cancers.

Review 7. Role of N6-methyladenosine modification in cancer.

Review 8. Cross Talk between Radiation and Immunotherapy: The Twain Shall Meet.

Review 9. m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

Review 4. Regulation of Gene Expression by N⁶-methyladenosine in Cancer.

Review 7. Role of N⁶-methyladenosine modification in cancer.

Review 9. m⁶A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.